Utah People's Post

The Latest News from the Beehive State

Tuesday, January 19, 2021
Log in
  • National News
    • Female Caseworker Killed & Doctor Shot in Philadelphia
  • State News
    • Car Chase Leads to Drug Arrest
  • Tech & Science
  • Health
    • How to Prepare For Ticks Season
    • Magical Weight Loss Bean Scam
  • Sports
  • Business
You are here: Home / Health / Trial Ebola Drug Ready to be Offered by Japan

Trial Ebola Drug Ready to be Offered by Japan

Posted by

A Japanese company has been developing their own experimental drug for the Ebola virus, and Tokyo stands ready to offer this drug in the attempts of stemming the global tide of the deadly virus.

Yoshihidie Suga, chief cabinet secretary stated on Monday that Japan is ready to provide the experimental drug (which is yet to be approved) and that the manufacturer is also prepared to cooperate with authorities if and when the World Health Organization should request it.

download (12)

The World Health Organization has been considering the use of experimental drugs as a way of limiting the extension of the Ebola outbreak that has been wreaking havoc in western Africa. The outbreak has already taken more than 1,400 human lives, while thousands more people are infected.

With the WHO declaring the latest outbreak a global public health emergency, authorities have been exhausting all their resources in attempting to limit the virus from spreading.

Epidemiologists believe that death rates (that still aren’t as high as one would expect from the deadly virus) show that the outbreak is still young but that as the illness evolves in those patients that have been recently infected, we will be seeing increases in death rates.

An intense ethical debate has begun after the United States government allowed that two American and a Spanish patient infected with the Ebola virus be treated with the unapproved drug ZMapp. After the drug had shown promising results in tests on primates, authorities took the risk and gave the experimental drug to patients who had been recently flown into the United States after contracting the virus in West Africa. The drug (currently in very short supply) is showing promising results in the two Americans as well. The Spanish priest treated with ZMapp lost his life.

Mapp Biopharmaceutica, the US Company producing the experimental drug ZMapp will be sending all available supplies to West Africa.

A panel of experts analyzed the situation and decided that it is “ethical” that experimental treatments be used in this extreme situation, according to the WHO.

Spokesperson Takao Aoki, for the Japanese company producing the experimental drug, stated that Fujifilm Holdings (which had recently diversified into healthcare) is prepared to respond to individual requests for extreme cases. He added that Avigan, a drug that is currently in clinical tests in the US, is ready to be shipped if need be. Aoki explained that the company has enough stockpiles for 20,000 people and that all that needs to be determined is the conclusion that the WHO reaches.

Share this:

  • Tweet
  • Share on Tumblr
  • Email

Filed Under: Health, National News Tagged With: avigan, ebola drug, Ebola outbreak, ebola treatment, experimental drug, japanese ebola drug, West Africa, zmapp

Woman working out at the gym

Just 23% of Americans Are Working Out Enough in Their Spare Time

By

Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

By

United Airlines airplane

Passenger Mysteriously Dies on United Airlines flight Bound for Boston

By

Breakfast sandwich

Here Are Some Foods No Nutritionist Would Ever Eat

By

Poppy flower

UN Warns of Surge in Opium-based Drugs and Cocaine Supply

By

U.S.-Canada border

French Jogger Detained 2 Weeks for Accidentally Crossing Border

By

Plus size model

Normalizing Plus Size Could Fuel Obesity Crisis (Study)

By

Giant manta ray

Unique Manta Ray Nursery Spotted off Texas Coast

By

The rainbow flag

WHO Scraps Transgenderism from List of Mental Illnesses

By

456 People Dead at U.K. Hospital after Taking too Many Painkillers

By

Kenyan girls dancing

Kenyans Facing Poor Nutrition as Supermarket Shopping Is on the Rise

By

Pages

  • About
  • Contact
  • Privacy Policy GDPR
  • Staff
  • Terms and Conditions

Recent Posts

  • Just 23% of Americans Are Working Out Enough in Their Spare Time
  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)
  • Passenger Mysteriously Dies on United Airlines flight Bound for Boston
  • Here Are Some Foods No Nutritionist Would Ever Eat
  • UN Warns of Surge in Opium-based Drugs and Cocaine Supply
  • French Jogger Detained 2 Weeks for Accidentally Crossing Border
  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

Related Articles

  • Woman working out at the gym

    Just 23% of Americans Are Working Out Enough in Their Spare Time

  • Poliovirus Therapy Gives Brain Cancer Patients New Hope (Study)

  • Breakfast sandwich

    Here Are Some Foods No Nutritionist Would Ever Eat

  • U.S.-Canada border

    French Jogger Detained 2 Weeks for Accidentally Crossing Border

  • Normalizing Plus Size Could Fuel Obesity Crisis (Study)

  • The rainbow flag

    WHO Scraps Transgenderism from List of Mental Illnesses

  • 456 People Dead at U.K. Hospital after Taking too Many Painkillers

  • Billboard on Texas Interstate Kindly Asking Liberals to Leave

  • Young woman affected by depression

    If You Have PTSD You Were Likely Abused as a Child

  • Obese dog on a leash

    Obese Dogs Can Help Us Better Understand How Obesity Works

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Provo
  • Salt Lake News
  • Science
  • Sports
  • State News
  • Tech & Science
  • Technology
  • Uncategorized
  • West Jordan
  • West Valley City
  • World

Copyright © 2021 utahpeoplespost.com

About · Privacy Policy · Terms of Use · Site Map · Contact

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This website uses cookies to ensure you get the best experience on our website. Learn more.